Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder

NCT: NCT05810636 · ENROLLING_BY_INVITATION

NCT IDNCT05810636
StatusENROLLING_BY_INVITATION
Start Date2022-02-16
Completion2026-12-31
SponsorNational Taiwan University Hospital (OTHER)
First posted
Last updated

Brief Summary

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Clinical diagnosis of this disorder depends of history taking, parent report, and questionnaire. Attention test such as continuous performance test can provide quantitative measurement on attention deficits; however, there is a lack of objective tool to quantify the activity level. This study aims to assess activity level in children with ADHD. We plan to recruit 50 children with ADHD and 50 neurotypical children. The activity level measured by wearable device will be compared between ADHD and neurotypical children. The correlation between behavior rating on questionnaire and quantitative data measured by wearable device will be analyzed.

Frequently Asked Questions

What is Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder?

Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder is a clinical trial registered under NCT05810636. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT05810636?

The current status of NCT05810636 (Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder) is: ENROLLING_BY_INVITATION.

When did Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder start?

Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder started on 2022-02-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.